Lilly Beats Forecast, Helped by Drug Soon to Face Generics

mercredi 24 juillet 2013

Eli Lilly and Co reported higher-than-expected quarterly earnings, helped by cost cuts and strong sales of Cymbalta, a depression treatment that will lose patent protection by year end, and the drugmaker ...



via Business & Finance News - Yahoo! Finance http://finance.yahoo.com/news/lilly-beats-forecast-helped-drugs-104322977.html

0 commentaires:

Enregistrer un commentaire